Clinical Trial Update: Effect of Tetracaine on Pain Management and Corneal Healing in Patients With Acute Corneal Abrasion [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating tetracaine for pain management and corneal healing in acute corneal abrasion has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Abrasion

Drugs mentioned

• Tetracaine (Tetracaine)

Snippet

Sponsor: Queen's University | Conditions: Corneal Abrasion | Phase 3 | Status: WITHDRAWN